| Apo Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) | | homo-2-mer | 8-311 | 100 | 1×DMS; |
|
| MAP4K4 in complex with inhibitor (compound 6) | | homo-2-mer | 10-311 | 100.0 | 1×3D8; |
|
| MAP4K4 Bound to inhibitor compound 1 | | homo-2-mer | 12-311 | 100.0 | 1×3C8; 1×MG; 1×MES; |
|
| MAP4K4 in complex with inhibitor (compound 16) | | homo-2-mer | 12-311 | 100.0 | 1×MES; 1×NA; 1×3D9; |
|
| MAP4K4 in complex with inhibitor (compound 25) | | homo-2-mer | 12-311 | 100.0 | 2×MG; 1×3DC; 1×MES; |
|
| MAP4K4 in complex with inhibitor (compound 31), N-[3-(4-AMINOQUINAZOLIN-6-YL)-5-FLUOROPHENYL]-2-(PY… | | homo-2-mer | 13-311 | 100.0 | 1×MES; 1×MG; 1×2QT; |
|
| Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) Bound to AMPPNP | | homo-2-mer | 13-311 | 100 | 1×ANP; 3×MG; |
|
| MAP4K4 in complex with a pyridin-2(1H)-one derivative | | homo-2-mer | 13-311 | 100.0 | 1×3XM; 1×MES; |
|
| MAP4K4 in complex with inhibitor GNE-495 | | homo-2-mer | 13-311 | 100.0 | 1×MG; 1×MES; 1×4P4; |
|
| APO MAP4K4 T181E Phosphomimetic Mutant | | homo-2-mer | 14-311 | 99.66 | 2×MES; 1×NA; |
|
| MAP4K4 T181E Mutant Bound to inhibitor compound 1 | | homo-2-mer | 16-310 | 100.0 | 1×MES; 2×3C8; 2×MG; |
|
| MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AM… | | monomer | 13-310 | 100.0 | 1×MG; 1×MES; 1×2QU; |
|
| MAP4K4 in complex with an inhibitor | | monomer | 13-309 | 100.0 | 1×5DF; |
|
| MAP4K4 in complex with inhibitor | | monomer | 14-309 | 100.0 | 1×4QG; |
|
| MAP4K4 in complex with inhibitor | | monomer | 14-309 | 100.0 | 1×6HH; |
|
| MAP4K4 in complex with inhibitor (compound 22), 6-(3-CHLOROPHENYL)QUINAZOLIN-4-AMINE | | monomer | 16-310 | 100.0 | 1×MES; 1×NA; 1×2QV; |
|
| MAP4K4 in complex with inhibitor compound 12 (N3-methyl-10-(3-methyl-3-(5-methyloxazol-2-yl)but-1-y… | | monomer | 17-311 | 100.0 | 1×9X4; |
|